Why detrusan

detrusan® represents a breakthrough in incontinence therapy!

It was originally designed in Europe and has been used in hospitals and clinics in various countries since 1995 with outstanding results. Clinical studies have shown detrusan to be highly effective when treating most incontinence cases. detrusan is CE marked; it has obtained FDA approval and is now available worldwide for the treatment of Urinary Incontinence.

 

Design

detrusan has been designed to take advantage of decades of clinical research. It incorporates a wide variety of stimulation protocols that have been optimized for specific conditions. detrusan therapy is simple and its results are long-lasting.

It provides a means to exercise the Urethral Sphincters and the Detrusor. This therapy does not rely on medication or surgery, and it offers a highly effective alternative to re-tone the bladder muscles and gain urinary control.

Each therapy session lasts approximately 15 minutes and delivers optimized Electrical Stimulation to the bladder muscles. There is no pain. This special electric signal controls the muscles and builds their tone back.

It can be used with rectal probes for both men and women. A patented special transurethral catheter has been developed and offers the most powerful stimulation results for bladder control in the world. Catheters are available in three different sizes to facilitate use depending on the size of the patient

Engineered Solution

detrusan has been engineered to incorporate the best features and electrical parameters based on the valuable input from key researchers around the world.

The best results of bladder stimulation therapy are obtained when the appropriate stimulation parameters are used in conjunction with the catheter or probe. Therapy should start an hour after the last micrurition so that the bladder can contain at least 125 ml of fluid during the therapy.

This maximizes the transfer of ions throughout the inner bladder walls and the rehabilitation effects.